Fresh off a big clinical trial victory in postpartum depression, Sage Therapeutics (SAGE) announced yet more good news Thursday: Positive results from a mid-stage clinical trial for a pill to treat people with major depressive disorder. The drug appears to work quickly, though its effects diminish over time.
If Thursday’s results are confirmed in later phase 3 clinical trials, the Sage pill, known as SAGE-217, could become one of the first medicines in years with a new mechanism of action to be approved for the treatment of depression.
Very cool – 60% response in that first readout. I highly doubt there is any pill that will ever cure depression long term though, psychopharmacology with life changes are required.
Boston Globe – please don’t link to “pay” Stat articles from bostonglobe.com as if they’re just normal Globe articles. It’s really annoying.
Absolutely. I refuse to buy Stat.
Comments are closed.